Skip to content
Gold Mining News – Lifestyle
Home
Sample Page
Author:
Tevogen Bio Inc
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
July 13, 2026
Tevogen Announces Formation of a Healthcare Services Initiative
June 9, 2026
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
May 28, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 21, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 12, 2026
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 26, 2026
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
1
2
Next Page
→